Cargando…
Identification of Potential Prognostic Biomarkers Associated with Monocyte Infiltration in Lung Squamous Cell Carcinoma
The five-year survival rate of lung squamous cell carcinoma is significantly lower than that of other cancer types. It is therefore urgent to discover novel prognosis biomarkers and therapeutic targets and understand their correction with infiltrating immune cells to improve the prognosis of patient...
Autores principales: | Liu, Hailin, Yan, Bo, Chen, Yulong, Pang, Juan, Li, Yue, Zhang, Zhenfa, Li, Chenguang, Qin, Tingting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388304/ https://www.ncbi.nlm.nih.gov/pubmed/35993054 http://dx.doi.org/10.1155/2022/6860510 |
Ejemplares similares
-
miR-195 suppresses metastasis and angiogenesis of squamous cell lung cancer by inhibiting the expression of VEGF
por: Liu, Hailin, et al.
Publicado: (2019) -
Identification of miRNA signature for predicting the prognostic biomarker of squamous cell lung carcinoma
por: Liu, Huanqing, et al.
Publicado: (2022) -
Tumor‐associated macrophages (TAMs)‐derived osteopontin (OPN) upregulates PD‐L1 expression and predicts poor prognosis in non‐small cell lung cancer (NSCLC)
por: Li, Yue, et al.
Publicado: (2021) -
POLE2 Serves as a Prognostic Biomarker and Is Associated with Immune Infiltration in Squamous Cell Lung Cancer
por: Wu, Zhen, et al.
Publicado: (2020) -
RGN as a prognostic biomarker with immune infiltration and ceRNA in lung squamous cell carcinoma
por: Liao, Yang, et al.
Publicado: (2023)